Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Calypte Selects Manufacturing Partner in China

By Labmedica staff writers
Posted on 25 May 2004
Manufacturing facilities in China for the company's fast HIV test have been announced by Calypte Biomedical Corp. More...
(Alameda, CA, USA). Calypte has selected Beijing Tiantan Biological Products Co., Ltd. (BTBP), a biotechnology company whose parent is the National Vaccine & Serum Institute.

Calypte will be responsible for supplying technology, manufacturing and quality control equipment, expertise, technical assistance, and technical support while BTBP supplies the manufacturing facilities where the Rapid HIV-1/2 antibody tests will be produced. Calypte will be in charge of day-to-day operations.

"We are very pleased with this memorandum of understanding whereby BTBP established the long-term cooperation relationship with Calypte and the new cooperation company will manufacture Calypte's HIV rapid products, as BTBP sees a great market potential for Calypte's Rapid HIV-1/2 antibody tests in the People's Republic of China as well as other parts of the world,” said Ni Daoming, chairman of BTBP.

"Our relationship with BTBP is expected to greatly accelerate our entry into the Chinese market,” said Dr. J. Richard George, president and CEO of Calypte.




Related Links:
Calypte

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.